Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.24% | 35.94% | 34.79% | 37.98% | -19.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.24% | 35.94% | 34.79% | 37.98% | -19.43% |
| Cost of Revenue | -21.92% | -20.35% | 164.48% | 170.81% | 131.71% |
| Gross Profit | 58.55% | 61.73% | 6.70% | 9.23% | -37.98% |
| SG&A Expenses | -6.78% | -4.90% | -14.79% | -12.76% | 8.73% |
| Depreciation & Amortization | 9.94% | 12.15% | 19.00% | 21.82% | 30.35% |
| Other Operating Expenses | 14.34% | 16.64% | -16.90% | -14.92% | -28.55% |
| Total Operating Expenses | 2.84% | 4.91% | -0.04% | 2.33% | 6.49% |
| Operating Income | 2.78% | 0.82% | 6.90% | 4.69% | -13.22% |
| Income Before Tax | 4.53% | 2.61% | 7.90% | 5.72% | -4.81% |
| Income Tax Expenses | -85.52% | -85.03% | 1,950.00% | 1,968.75% | 367.74% |
| Earnings from Continuing Operations | 4.78% | 2.87% | 7.30% | 5.10% | -5.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.78% | 2.87% | 7.30% | 5.10% | -5.07% |
| EBIT | 2.78% | 0.82% | 6.90% | 4.69% | -13.22% |
| EBITDA | -21.75% | -24.20% | 22.76% | 20.93% | -3.10% |
| EPS Basic | 4.77% | 2.89% | 7.26% | 5.15% | -5.16% |
| Normalized Basic EPS | 4.68% | 2.74% | 7.42% | 5.08% | -4.21% |
| EPS Diluted | 4.77% | 2.89% | 7.26% | 5.15% | -5.16% |
| Normalized Diluted EPS | 4.68% | 2.74% | 7.42% | 5.08% | -4.21% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |